naion semaglutide news More research needed on possible ocular side effects of semaglutides The obesity drug semaglutide (Wegovy)

This neurological shift makes calorie reduction feel less forced and more sustainable

SC Medicaid program to stop covering expensive weight loss drugs for obesity South Carolina was among 14 states that offered the medication for obesity as well as diabetes South Carolina will stop covering GLP-1 drugs such as Wegovy for weight loss on Jan

This medication is approved for adults striving to achieve healthier weight levels as part of a broad management plan

For women using automated insulin delivery (AID) systems, the ADA 2026 Standards include specific counseling guidance for pregnancy, including when to switch between automated and manual modes

Svoronos AA, OGrady CS, Walker EVAN, Afshari NA, Macias BR, Laurie SS, et al